 |
Inalimarev and falimarev |
|---|---|
| Trade Name | |
| Orphan Indication | Adenocarcinoma of the pancreas |
| USA Market Approval | USA |
| USA Designation Date | 2006-01-10 00:00:00 |
| Sponsor | Therion Biologics Corporation;76 Rogers Street;Cambridge, Massachusetts, 02142 |
| |
Inalimarev and falimarev |
|---|---|
| Trade Name | |
| Orphan Indication | Adenocarcinoma of the pancreas |
| USA Market Approval | USA |
| USA Designation Date | 2006-01-10 00:00:00 |
| Sponsor | Therion Biologics Corporation;76 Rogers Street;Cambridge, Massachusetts, 02142 |